Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;193(2):953-962.
doi: 10.1016/j.jss.2014.08.045. Epub 2014 Sep 1.

Cell recruitment by amnion chorion grafts promotes neovascularization

Affiliations

Cell recruitment by amnion chorion grafts promotes neovascularization

Zeshaan N Maan et al. J Surg Res. 2015 Feb.

Abstract

Background: Nonhealing wounds are a significant health burden. Stem and progenitor cells can accelerate wound repair and regeneration. Human amniotic membrane has demonstrated efficacy in promoting wound healing, though the underlying mechanisms remain unknown. A dehydrated human amnion chorion membrane (dHACM) was tested for its ability to recruit hematopoietic progenitor cells to a surgically implanted graft in a murine model of cutaneous ischemia.

Methods: dHACM was subcutaneously implanted under elevated skin (ischemic stimulus) in either wild-type mice or mice surgically parabiosed to green fluorescent protein (GFP) + reporter mice. A control acellular dermal matrix, elevated skin without an implant, and normal unwounded skin were used as controls. Wound tissue was harvested and processed for histology and flow cytometric analysis.

Results: Implanted dHACMs recruited significantly more progenitor cells compared with controls (*P < 0.05) and displayed in vivo SDF-1 expression with incorporation of CD34 + progenitor cells within the matrix. Parabiosis modeling confirmed the circulatory origin of recruited cells, which coexpressed progenitor cell markers and were localized to foci of neovascularization within implanted matrices.

Conclusions: In summary, dHACM effectively recruits circulating progenitor cells, likely because of stromal derived factor 1 (SDF-1) expression. The recruited cells express markers of "stemness" and localize to sites of neovascularization, providing a partial mechanism for the clinical efficacy of human amniotic membrane in the treatment of chronic wounds.

Keywords: Amniotic membrane; Chronic wounds; Hematopoietic progenitor cell; Neovascularization; Progenitor cell recruitment; SDF-1; dHACM.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fluorescence-activate cell sorting (FACS) analysis of HPCs in the implants and overlying skin. (A) A Lin-/CD45+/c-Kit+/Sca-1+ gating scheme was used to identify HPCs. (B) The relative number of HPCs in specimens of healthy skin, sham surgery sites, and control ADM are reduced compared with dHACM. ** indicates P ≤ 0.05 for dHACM compared with healthy skin and sham implant. ++ indicates P ≤ 0.05 for dHACM compared with control ADM. (Color version of the figure is available online.)
Fig. 2
Fig. 2
Immunohistochemistry for CD34 expression in dHACM and control groups. (A and B) Increased CD34 positive progenitor cells were visualized in the peri-implant space and skin overlying dHACM compared with controls. (C and D) Intraimplant CD34 + progenitor cell engraftment was increased in the dHACM group compared with control. ** indicates P ≤ 0.05 for dHACM compared with healthy skin and sham implant. ++ indicates P ≤ 0.05 for dHACM compared with control ADM. Scale bar: 50 μm. (Color version of the figure is available online.)
Fig. 3
Fig. 3
Flow cytometric analysis of GFP + cells in healthy skin, sham operated skin, control ADM, and dHACM after murine parabiosis. (A) Representative flow cytometry plots from day 7 samples identifying GFP + cells. (B) Flow cytometric quantification of GFP + cells showing increased recruitment by dHACM from day 3–day 14. ** indicates P ≤ 0.05 for dHACM compared with healthy skin and sham implant. ++ indicates P ≤ 0.05 for dHACM compared with control ADM. (Color version of the figure is available online.)
Fig. 4
Fig. 4
Immunohistochemistry of SDF-1 expression. (A) SDF-1 expression colocalizes with GFP expression in the dHACM group and (B) is relatively increased compared with controls. Scale bar: 50 μm. (Color version of the figure is available online.)
Fig. 5
Fig. 5
Immunohistochemistry of CD90 expression demonstrating coexpression with GFP and 4’,6-diamidino-2-phenylindole (DAPI) nuclear stain within dHACM implants. White arrows demonstrate CD90+, GFP + recruited cells. Scale bar: 25 μm. (Color version of the figure is available online.)
Fig. 6
Fig. 6
Immunohistochemical localization of recruited GFP + cells to sites of neovascularization. (A) GFP + cells are recruited to perivascular sites of CD31 expression within the dHACM; (B) a process that is relatively increased compared with control groups. Scale bar: 50 μm. (Color version of the figure is available online.)

Similar articles

Cited by

References

    1. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314. - PubMed
    1. Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763. - PMC - PubMed
    1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219. - PMC - PubMed
    1. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006;117:35S. - PubMed
    1. Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg. 2010;125:510. - PMC - PubMed

Publication types